A rare penetrant TIMP3 mutation confers relatively late onset choroidal neovascularisation which can mimic age-related macular degeneration
A rare penetrant TIMP3 mutation confers relatively late onset choroidal neovascularisation which can mimic age-related macular degeneration
Purpose
To perform a genotype–phenotype correlation for three patients heterozygous for a missense mutation in the tissue inhibitor of metalloproteinase 3 (TIMP3) gene.
Methods
Retrospective, observational case series. The medical records and photographs were reviewed for three patients diagnosed at the time with neovascular age-related macular degeneration (AMD). All were later found to carry a predicted C113G mutation in the TIMP3 gene, other known mutations in which are associated with Sorsby’s fundus dystrophy.
Results
All three patients developed drusen and bilateral choroidal neovascularisation with subsequent disciform scarring and atrophy. Visual acuity rapidly deteriorated to <6/60 in both eyes. The age of onset varied from 56 to 64 years and the interval to contralateral eye involvement varied from 4 to 6 years. Two of the three patients had a family history of AMD. All three patients were heterozygous for the C113G nucleotide change, resulting in a Ser38Cys change at the N terminus of the TIMP3 protein.
Conclusion
This case series suggests the C113G TIMP3 variant may represent a novel highly penetrant mutation causing choroidal neovascularisation of relatively late onset for Sorsby’s fundus dystrophy, mimicking early onset AMD.
2-4
Warwick, A.
eab9cc60-6a67-48a7-9210-580756aa17a7
Gibson, J.
855033a6-38f3-4853-8f60-d7d4561226ae
Sood, R.
5ca793d0-ce4a-48e6-a646-b1348ac4219f
Lotery, A.
5ecc2d2d-d0b4-468f-ad2c-df7156f8e514
Warwick, A.
eab9cc60-6a67-48a7-9210-580756aa17a7
Gibson, J.
855033a6-38f3-4853-8f60-d7d4561226ae
Sood, R.
5ca793d0-ce4a-48e6-a646-b1348ac4219f
Lotery, A.
5ecc2d2d-d0b4-468f-ad2c-df7156f8e514
Warwick, A., Gibson, J., Sood, R. and Lotery, A.
(2015)
A rare penetrant TIMP3 mutation confers relatively late onset choroidal neovascularisation which can mimic age-related macular degeneration.
Eye, .
(doi:10.1038/eye.2015.204).
(PMID:26493035)
Abstract
Purpose
To perform a genotype–phenotype correlation for three patients heterozygous for a missense mutation in the tissue inhibitor of metalloproteinase 3 (TIMP3) gene.
Methods
Retrospective, observational case series. The medical records and photographs were reviewed for three patients diagnosed at the time with neovascular age-related macular degeneration (AMD). All were later found to carry a predicted C113G mutation in the TIMP3 gene, other known mutations in which are associated with Sorsby’s fundus dystrophy.
Results
All three patients developed drusen and bilateral choroidal neovascularisation with subsequent disciform scarring and atrophy. Visual acuity rapidly deteriorated to <6/60 in both eyes. The age of onset varied from 56 to 64 years and the interval to contralateral eye involvement varied from 4 to 6 years. Two of the three patients had a family history of AMD. All three patients were heterozygous for the C113G nucleotide change, resulting in a Ser38Cys change at the N terminus of the TIMP3 protein.
Conclusion
This case series suggests the C113G TIMP3 variant may represent a novel highly penetrant mutation causing choroidal neovascularisation of relatively late onset for Sorsby’s fundus dystrophy, mimicking early onset AMD.
Text
Warwick et al_Eye_2015_TIMP3.pdf
- Accepted Manuscript
More information
Accepted/In Press date: 3 September 2015
e-pub ahead of print date: 23 October 2015
Organisations:
Centre for Biological Sciences, Clinical & Experimental Sciences
Identifiers
Local EPrints ID: 384127
URI: http://eprints.soton.ac.uk/id/eprint/384127
ISSN: 0950-222X
PURE UUID: fad33356-079c-4caf-95cb-5e1f056e4b04
Catalogue record
Date deposited: 17 Nov 2015 15:31
Last modified: 15 Mar 2024 03:17
Export record
Altmetrics
Contributors
Author:
A. Warwick
Author:
R. Sood
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics
